Capital International Investors Genmab A/S Transaction History
Capital International Investors
- $475 Billion
- Q2 2024
A detailed history of Capital International Investors transactions in Genmab A/S stock. As of the latest transaction made, Capital International Investors holds 4,227,965 shares of GMAB stock, worth $103 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,227,965
Previous 4,373,277
3.32%
Holding current value
$103 Million
Previous $131 Million
18.77%
% of portfolio
0.02%
Previous 0.03%
Shares
17 transactions
Others Institutions Holding GMAB
# of Institutions
232Shares Held
48.5MCall Options Held
6.8KPut Options Held
27.6K-
Alliancebernstein L.P. New York, NY15.2MShares$371 Million0.14% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$124 Million0.0% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.77MShares$67.3 Million0.4% of portfolio
-
Wellington Management Group LLP Boston, MA2.31MShares$56.1 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.46MShares$35.6 Million0.06% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $16B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...